Company intelligence / Profile preview

Furman Selz

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Furman Selz was a prominent U.S. investment bank and asset management firm that provided financial services, including investment banking expertise in healthcare and life sciences sectors. It was acquired by ING Group in 1997 and is no longer an active independent entity. It was not an operating life science, biotech, pharma, or healthcare company, therefore clinical pipeline, modalities, targets, and indications are not applicable to its operations.

Industry: Investors

Partnerships

Corporate finance, asset management, and investment banking collaboration with healthcare/biotech/pharma companiesParticipated as co-sponsor/investor in various healthcare, biotech and pharma deals (e.g., Athersys, Achillion Pharmaceuticals)

Beyond the preview

Go deeper on Furman Selz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Furman Selz.

Explore the full profile